veratrylglycerol-beta-guaiacyl ether: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
veratrylglycerol beta-guaiacyl ether : A idol that is propane-1,3-diol substituted by a 3,4-dimethoxyphenyl group at position 1 and a 2-methoxyphenoxy group at position 2 respectively. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
ID Source | ID |
---|---|
PubMed CID | 193461 |
CHEBI ID | 86963 |
SCHEMBL ID | 9579548 |
MeSH ID | M0136329 |
Synonym |
---|
1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol |
1,3-propanediol,1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)- |
veratrylglycerol-beta-guaiacyl ether |
veratrylglycerol-b-guaiacyl ether |
1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)-propane-1,3-diol |
BMSE010044 |
BMSE010045 |
10535-17-8 |
1-(3,4-dimethoxy-phenyl)-2-(2-methoxy-phenoxy)-propane-1,3-diol |
AKOS015920405 |
1-(4-o(14)ch3-3-methoxyphenyl)-2-(2-methoxyphenoxy)propane-1,3-diol |
vgbe |
1,3-propanediol, 1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)- |
1-(3,4-dimethoxyphenyl)-1,3-dihydroxy-2-(2-methoxyphenoxy)propane |
FT-0648302 |
c18h22o6 |
2-(2-methoxyphenoxy)-3-(3,4-dimethoxyphenyl)propane-1,3-diol |
mfcd01880862 |
1-(3,4-dimethoxyphenyl)-1,3-dihydroxy-(2-methoxyphenyl)-propan |
IEWUCQVFAWBYOC-UHFFFAOYSA-N , |
SCHEMBL9579548 |
C21419 |
veratrylglycerol beta-guaiacyl ether |
CHEBI:86963 |
1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)-1,3-propanediol |
methoxyphenoxy)propane-1 ,3-diol |
1 -(3,4-dimethoxyphenyl)-2-(2- |
CS-D0574 |
Q27159299 |
SY045899 |
DS-13329 |
A848606 |
DTXSID50909458 |
1-(3 pound not4-dimethoxy-phenyl)-2-(2-methoxy-phenoxy)-propane-1 pound not3-diol |
Class | Description |
---|---|
dimethoxybenzene | Any methoxybenzene that consists of a benzene skeleton substituted with two methoxy groups and its derivatives. |
diol | A compound that contains two hydroxy groups, generally assumed to be, but not necessarily, alcoholic. Aliphatic diols are also called glycols. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.17) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |